Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Finished Goods (2016 - 2026)

Standard Biotools has reported Finished Goods over the past 15 years, most recently at $11.1 million for Q4 2025.

  • Quarterly Finished Goods rose 52.85% to $11.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.1 million through Dec 2025, up 52.85% year-over-year, with the annual reading at $11.1 million for FY2025, 52.85% up from the prior year.
  • Finished Goods was $11.1 million for Q4 2025 at Standard Biotools, down from $12.7 million in the prior quarter.
  • Over five years, Finished Goods peaked at $15.2 million in Q4 2022 and troughed at $7.3 million in Q4 2023.
  • The 5-year median for Finished Goods is $11.0 million (2021), against an average of $11.0 million.
  • Year-over-year, Finished Goods surged 60.21% in 2021 and then plummeted 52.38% in 2023.
  • A 5-year view of Finished Goods shows it stood at $10.6 million in 2021, then soared by 43.64% to $15.2 million in 2022, then plummeted by 52.38% to $7.3 million in 2023, then changed by 0.0% to $7.3 million in 2024, then skyrocketed by 52.85% to $11.1 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Finished Goods are $11.1 million (Q4 2025), $12.7 million (Q3 2025), and $13.9 million (Q2 2025).